CoChat

Non-CPAP therapies in obstructive sleep apnoea

Open access

The DOI matches its Crossref record; 401 of the 426 references it cites were found in a registry or an index; 54 of the 579 sources its claims cite were checked for support.

Abstract

In view of the high prevalence and the relevant impairment of patients with obstructive sleep apnoea syndrome (OSAS) lots of methods are offered which promise definitive cures for or relevant improvement of OSAS. This report summarises the efficacy of alternative treatment options in OSAS. An interdisciplinary European Respiratory Society task force evaluated the scientific literature according to the standards of evidence-based medicine. Evidence supports the use of mandibular advancement devices in mild to moderate OSAS. Maxillomandibular osteotomy seems to be as efficient as continuous positive airway pressure (CPAP) in patients who refuse conservative treatment. Distraction osteogenesis is usefully applied in congenital micrognathia or midface hypoplasia. There is a trend towards improvment after weight reduction. Positional therapy is clearly inferior to CPAP and long-term compliance is poor. Drugs, nasal dilators and apnoea triggered muscle stimulation cannot be recommended as effective treatments of OSAS at the moment. Nasal surgery, radiofrequency tonsil reduction, tongue base surgery, uvulopalatal flap, laser midline glossectomy, tongue suspension and genioglossus advancement cannot be recommended as single interventions. Uvulopalatopharyngoplasty, pillar implants and hyoid suspension should only be considered in selected patients and potential benefits should be weighed against the risk of long-term side-effects. Multilevel surgery is only a salvage procedure for OSA patients.

Overview

CoChat Summary

TL;DR

This European Respiratory Society task force report evaluates non-CPAP therapies for obstructive sleep apnoea using evidence-based medicine criteria. It recommends mandibular advancement devices for mild-to-moderate OSA, maxillomandibular advancement in selected CPAP-refusing patients, weight reduction, and selected surgical procedures, while rejecting drugs, nasal dilators, apnoea-triggered stimulation, and many single-level surgeries.

Key findings

  • Mandibular advancement devices (MADs) are recommended for mild to moderate OSA (A); they reduce sleep apnoeas and subjective daytime sleepiness and improve quality of life versus controls. Treatment success with MAD, defined as AHI <5, occurred in 19–75% of patients, and AHI <10 in 30–94%; 76% continued treatment after 1 yr and 65% after 4 yrs. CPAP reduced sleep apnoeas more effectively, but symptom and health effects were more similar, and patients generally preferred MADs.
  • Weight reduction was associated with improvement in breathing pattern, sleep quality and daytime sleepiness (C). Diet studies showed mean BMI reduction of 4.7±2.5 kg·m⁻² with AHI decrease of 21±13 h⁻¹ (44%); 39% had partial improvement and 23% were cured. Surgical weight-loss studies showed AHI decrease of 44±22 h⁻¹ (77%); 34.2% had partial improvement and 64.4% were cured. Pharmaceutical studies showed BMI change of 1.8–2.6 kg·m⁻² and AHI decrease of 2.8–16.3 h⁻¹ (7–35.6%).
  • Positional therapy can yield moderate AHI reductions but is clearly inferior to CPAP, and long-term compliance is poor; only 29% used a positional vest after 2 yrs. It is not recommended except in carefully selected patients (C).
  • Maxillomandibular advancement seems as efficient as CPAP in selected patients who refuse conservative treatment, particularly younger patients without excessive BMI or comorbidities (B). UPPP has a reported success rate of ∼50% in unselected mild-to-moderate sleep apnoea and 30–78% in prospective studies, but long-term side-effects persisted in 58%; it cannot be recommended except in carefully selected patients (C). Multilevel surgery is only a salvage procedure (C), with success rates varying from 22.7% to 78% (mean 60.9%) and a meta-analytic success rate of 66.4% with 14.6% complications. Drugs, nasal dilators, and apnoea-triggered muscle stimulation cannot be recommended as effective treatments.

Methods

  • An interdisciplinary European Respiratory Society task force performed individualised literature searches in PubMed and Medline, hand searches, and reference-list screening up to January 1, 2009, with an additional May 2010 screen for newer papers. Reviews, guidelines, and case reports were excluded; studies were included only if data from at least three subjects were available and sleep testing used polygraphy or polysomnography.
  • Studies were evaluated using the Oxford Centre for Evidence-Based Medicine levels of evidence (1a–5), and recommendation grades A–D were assigned. Changes were considered significant at p<0.05 unless stated otherwise; pre- versus postoperative differences were assessed with Mann–Whitney U- or paired t-tests as appropriate.
  • The report covers conservative and surgical non-CPAP therapies for OSA; central sleep apnoea and periodic breathing were not the focus.

Limitations

  • The paper states that many included studies were retrospective and observational case series, often with low-level evidence, selection biases, short follow-up, and no randomised trials for several procedures. It also notes a lack of consensus on definitions of surgical success and heterogeneity in outcome measures.
  • The paper states that no long-term follow-up studies have been performed on sleepiness, the primary symptom of OSA, and that population-based studies on the spontaneous course of OSA are lacking.
  • Evident from the text: the main literature search ended January 1, 2009, with only a limited May 2010 update, so later evidence is not incorporated; several conclusions rest on small, uncontrolled, or single-centre studies, and some analyses could not express an overall weight-change-to-AHI relationship because weight changes were reported inconsistently.

Model-written summary. Check it against the paper before relying on it.

Integrity signals

Registry

Crossref · 10.1183/09031936.00099710

Cites

401 of 401 references verified0 citation errors · 0 not checkable

Statistics

Nothing to recompute.

Verification

Claims the paper makes

44 Valid · 36 Not valid · 218 Not checked · 162 Own results and interpretations

195 more claims · 24 with their cited sources checked

Create a free account to see all 460 claims and to verify the 12 references still open.

See all claims — free account
  • Not yet classified. 70
  • It may state two separate claims as one. 118
  • Probably not a substantial claim. 88
  • The quote only partly states this claim. 4

Create a free account to see these claims.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

Each contradiction between two passages listed here was confirmed by an independent check.

3 of 3

Citations

Cites

Show all 401 references

Research works printed but not linked: 1

  1. Phillips B Ball C . Levels of Evidence and Grades of Recommendation. Oxford, Oxford Centre for Evidence-Based Medicine, 2001

Cited by

See all 388

Metadata

Authors
Randerath, W. J., Verbraecken, J., Andreas, S., Bettega, G., Boudewyns, A., Hamans, E., Jalbert, F., Paoli, J. R., Sanner, B., Smith, I., Stuck, B. A., Lacassagne, L., Marklund, M., Maurer, J. T., Pepin, J. L., Valipour, A., Verse, T., & Fietze, I.
Affiliations
Witten/Herdecke University (DE)
Venue
European Respiratory Journal
Published
2011-03-15
Volume
37
Issue
5
Pages
1000-1028
ISSN
  • 0903-1936 (ISSN-L)
  • 1399-3003
OpenAlex
W2114345963
Cited by
388
References
426
Citations by year
2026: 15 · 2025: 16 · 2024: 20 · 2023: 18 · 2022: 14 · 2021: 26 · 2020: 29 · 2019: 21 · 2018: 22 · 2017: 20 · 2016: 38 · 2015: 37 · 2014: 56 · 2013: 24 · 2012: 22
FWCI
24.01
Type
journal article
Language
en
Open access
Locations
  • European Respiratory Journal (publishedVersion)
  • PubMed (publishedVersion)
Funders
Universitair Ziekenhuis Antwerpen
Topics
  • Health Sciences › Medicine › Physiology (medical) › Obstructive Sleep Apnea Research
  • Health Sciences › Dentistry › Oral Surgery › Temporomandibular Joint Disorders
  • Social Sciences › Psychology › Experimental and Cognitive Psychology › Sleep and related disorders
Keywords
obstructive sleep apnea, mandibular advancement device, distraction osteogenesis, midface hypoplasia, weight loss, positional therapy, nasal dilator, uvulopalatopharyngoplasty, hyoid suspension, multilevel surgery, treatment efficacy
MeSH terms
Adolescent, Adult, Aged, Aged, 80 and over, Child, Child, Preschool, Female, Humans, Hyoid Bone, Male, Middle Aged, Nose, Palate, Pharynx, Severity of Illness Index, Tongue, Salvage Therapy, Mandibular Advancement, Osteogenesis, Distraction, Sleep Apnea, Obstructive, Continuous Positive Airway Pressure, Young Adult

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

The claim verdicts this report counts are experimental: their accuracy is not yet measured.

A language model drew the claims from the paper on 2026-09-28, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).

A second model labelled each claim on 2026-09-28 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).

Cited sources are checked with a language model’s help (gpt-6-sol).

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Non-CPAP therapies in obstructive sleep apnoea. https://app.cochat.ai/papers/10.1183/09031936.00099710
The paper
Randerath, W. J., Verbraecken, J., Andreas, S., Bettega, G., Boudewyns, A., Hamans, E., Jalbert, F., Paoli, J. R., Sanner, B., Smith, I., Stuck, B. A., Lacassagne, L., Marklund, M., Maurer, J. T., Pepin, J. L., Valipour, A., Verse, T., & Fietze, I. (2011). Non-CPAP therapies in obstructive sleep apnoea. European Respiratory Journal. https://doi.org/10.1183/09031936.00099710

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.